share_log

华邦健康(002004.SZ)：控股子公司凯盛新材主要从事精细化工产品及新型高分子材料的研发、生产和销售

Huabang Health (002004.SZ): The holding subsidiary Kaisheng New Materials is mainly engaged in R&D, production and sales of fine chemical products and new polymer materials

Gelonghui Finance ·  Mar 13 03:25

Gelonghui, March 13 | Huabang Health (002004.SZ) said on the investor interactive platform that the company's holding subsidiary Kaisheng New Materials is mainly engaged in R&D, production and sales of fine chemical products and novel polymer materials. The business covers inorganic chemicals, carboxyl chlorides, hydroxychlorides, and the novel polymer material polyether ketone. The main products include inorganic chemicals (including sulfoxide chloride and sulfuryl chloride), carboxyl chloride (including aramid polymer monomers, para-nitrobenzoyl chloride, chloroacetyl chloride, etc.), hydroxychlorides (including chloroacetyl chloride, etc.), hydroxychlorides (including chloroacetyl chloride, etc.), hydroxy chlorides (including chloroacetyl chloride, etc.), and polychlorochlorides (including polychlorinated polymers) ether ketone ketone, etc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment